Yuri V. Khramtsov

578 total citations
38 papers, 447 citations indexed

About

Yuri V. Khramtsov is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Yuri V. Khramtsov has authored 38 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Infectious Diseases. Recurrent topics in Yuri V. Khramtsov's work include RNA Interference and Gene Delivery (21 papers), Advanced biosensing and bioanalysis techniques (18 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Yuri V. Khramtsov is often cited by papers focused on RNA Interference and Gene Delivery (21 papers), Advanced biosensing and bioanalysis techniques (18 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Yuri V. Khramtsov collaborates with scholars based in Russia, Tajikistan and United States. Yuri V. Khramtsov's co-authors include Alexander S. Sobolev, Andrey A. Rosenkranz, A. V. Ulasov, Tatiana A. Slastnikova, E. D. Sverdlov, Georgii P. Georgiev, Mikhail Durymanov, G. P. Georgiev, Raymond M. Schiffelers and Michael R. Zalutsky and has published in prestigious journals such as Biomaterials, Cancer Research and Journal of Controlled Release.

In The Last Decade

Yuri V. Khramtsov

33 papers receiving 431 citations

Peers

Countries citing papers authored by Yuri V. Khramtsov

Since Specialization

Citations

This map shows the geographic impact of Yuri V. Khramtsov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuri V. Khramtsov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuri V. Khramtsov more than expected).

Fields of papers citing papers by Yuri V. Khramtsov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuri V. Khramtsov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuri V. Khramtsov. The network helps show where Yuri V. Khramtsov may publish in the future.

Co-authorship network of co-authors of Yuri V. Khramtsov

This figure shows the co-authorship network connecting the top 25 collaborators of Yuri V. Khramtsov. A scholar is included among the top collaborators of Yuri V. Khramtsov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuri V. Khramtsov. Yuri V. Khramtsov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modular Nanotransporters Deliver Anti-Keap1 Monobody into Mouse Hepatocytes, Thereby Inhibiting Production of Reactive Oxygen Species 2024 ·Pharmaceutics ·Yuri V. Khramtsov, A. V. Ulasov, Andrey A. Rosenkranz, Tatiana A. Slastnikova, (unknown), Georgii P. Georgiev, Alexander S. Sobolev	1
2	Optimization of a Modular Nanotransporter Design for Targeted Intracellular Delivery of Photosensitizer 2024 ·Pharmaceutics ·(unknown), A. V. Ulasov, Yuri V. Khramtsov, Tatiana A. Slastnikova, (unknown), (unknown), Georgii P. Georgiev, Andrey A. Rosenkranz	0
3	An Approach to Evaluate the Effective Cytoplasmic Concentration of Bioactive Agents Interacting with a Selected Intracellular Target Protein 2023 ·Pharmaceutics ·Yuri V. Khramtsov, A. V. Ulasov, Andrey A. Rosenkranz, Tatiana A. Slastnikova, (unknown), Georgii P. Georgiev, Alexander S. Sobolev	6
4	Modular Nanotransporters Capable of Causing Intracellular Degradation of the N-Protein of the SARS-CoV-2 Virus in A549 Cells with Temporary Expression of This Protein Fused with a Fluorescent Protein mRuby3 2023 ·Doklady Biochemistry and Biophysics ·Yuri V. Khramtsov, A. V. Ulasov, (unknown), G. P. Georgiev, Alexander S. Sobolev	0
5	Modular Nanotransporters Delivering Biologically Active Molecules to the Surface of Mitochondria 2023 ·Pharmaceutics ·Yuri V. Khramtsov, A. V. Ulasov, Tatiana A. Slastnikova, Andrey A. Rosenkranz, (unknown), Georgii P. Georgiev, Alexander S. Sobolev	3
6	Targeted Delivery of 111In Into the Nuclei of EGFR Overexpressing Cells via Modular Nanotransporters With Anti-EGFR Affibody 2020 ·Frontiers in Pharmacology ·(unknown), A. V. Ulasov, Tatiana A. Slastnikova, Andrey A. Rosenkranz, (unknown), Yuri V. Khramtsov, Georgii P. Georgiev, Alexander S. Sobolev	17
7	New Recombinant Carriers Binding Specifically to the Epidermal Growth Factor Receptor 2020 ·Doklady Biochemistry and Biophysics ·(unknown), A. V. Ulasov, Andrey A. Rosenkranz, Tatiana A. Slastnikova, Yuri V. Khramtsov, (unknown), G. P. Georgiev, Alexander S. Sobolev	1
8	Low-resolution structure of modular nanotransporters obtained by small-angle X-ray scattering method 2018 ·RWTH Publications (RWTH Aachen) ·(unknown), Yuri V. Khramtsov, A.V. Vlasov, A. I. Kuklin, Valentin Gordeliy, Alexander S. Sobolev	1
9	Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression 2018 ·Frontiers in Pharmacology ·Andrey A. Rosenkranz, Tatiana A. Slastnikova, Т. А. Кармакова, (unknown), Н. Б. Морозова, (unknown), (unknown), Yuri V. Khramtsov, (unknown), A. V. Ulasov, R. I. Yakubovskaya, Georgii P. Georgiev, Alexander S. Sobolev	36
10	Characterization of new modular nanotransporters with albumin-binding domain 2017 ·Doklady Biochemistry and Biophysics ·Yuri V. Khramtsov, A. V. Ulasov, (unknown), Andrey A. Rosenkranz, (unknown), Alexander S. Sobolev	6
11	Development and evaluation of a new modular nanotransporter for drug delivery into nuclei of pathological cells expressing folate receptors 2017 ·Drug Design Development and Therapy ·Tatiana A. Slastnikova, Andrey A. Rosenkranz, Yuri V. Khramtsov, (unknown), (unknown), Alexander S. Sobolev	22
12	Antitumor efficacy of Auger electron emitter 111In delivered by modular nanotransporter into the nuclei of cells with folate receptor overexpression 2017 ·Doklady Biochemistry and Biophysics ·Andrey A. Rosenkranz, Tatiana A. Slastnikova, Yuri V. Khramtsov, (unknown), G. P. Georgiev, Alexander S. Sobolev	10
13	Live imaging of transgene expression in Cloudman S91 melanoma cells after polyplex-mediated gene delivery 2015 ·Journal of Controlled Release ·Mikhail Durymanov, (unknown), Yuri V. Khramtsov, Andrey A. Rosenkranz, Alexander S. Sobolev	14
14	Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer 2015 ·Journal of Translational Medicine ·(unknown), E. V. Snezhkov, И. П. Чернов, (unknown), V. K. Potapov, (unknown), G.S. Monastyrskaya, E. P. Kopantzev, Т В Виноградова, Yuri V. Khramtsov, A. V. Ulasov, Andrey A. Rosenkranz, Alexander S. Sobolev, (unknown), (unknown), (unknown), R. I. Yakubovskaya, E. D. Sverdlov	29
15	Use of intracellular transport processes for targeted drug delivery into a specified cellular compartment 2014 ·Biochemistry (Moscow) ·Andrey A. Rosenkranz, A. V. Ulasov, Tatiana A. Slastnikova, Yuri V. Khramtsov, Alexander S. Sobolev	17
16	Subcellular trafficking and transfection efficacy of polyethylenimine–polyethylene glycol polyplex nanoparticles with a ligand to melanocortin receptor-1 2012 ·Journal of Controlled Release ·Mikhail Durymanov, (unknown), A. V. Ulasov, Yuri V. Khramtsov, (unknown), (unknown), Tatiana A. Slastnikova, T. V. Vinogradova, (unknown), (unknown), Andrey A. Rosenkranz, Е. Д. Свердлов, Alexander S. Sobolev	32
17	Properties of PEI-based Polyplex Nanoparticles That Correlate With Their Transfection Efficacy 2010 ·Molecular Therapy ·A. V. Ulasov, Yuri V. Khramtsov, (unknown), Andrey A. Rosenkranz, E. D. Sverdlov, Alexander S. Sobolev	71
18	Modular drug transporters with diphtheria toxin translocation domain form edged holes in lipid membranes 2008 ·Journal of Controlled Release ·Yuri V. Khramtsov, Tatyana I. Rokitskaya, Andrey A. Rosenkranz, (unknown), (unknown), Yuri N. Antonenko, Alexander S. Sobolev	18
19	A study of pore formation in lipid bilayers by modular nanotransporters containing the diphtheria toxin translocation domain 2008 ·Doklady Biochemistry and Biophysics ·Andrey A. Rosenkranz, Yuri V. Khramtsov, (unknown), Н. В. Гнучев, Alexander S. Sobolev	6
20	Targeting Cancer Cells by Novel Engineered Modular Transporters 2006 ·Cancer Research ·(unknown), Andrey A. Rosenkranz, Pavel V. Gulak, В. Г. Лунин, (unknown), Yuri V. Khramtsov, (unknown), Mikhail A. Grin, А. Ф. Миронов, Andrey B. Rubin, Georgii P. Georgiev, Alexander S. Sobolev	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact